Show simple item record

dc.contributor.authorYan, Z
dc.contributor.authorYao, X
dc.contributor.authorPan, R
dc.contributor.authorZhang, J
dc.contributor.authorMa, X
dc.contributor.authorDong, N
dc.contributor.authorWei, J
dc.contributor.authorLiu, K
dc.contributor.authorQiu, Y
dc.contributor.authorSealey, K
dc.contributor.authorNichols, H
dc.contributor.authorJarvis, Michael A
dc.contributor.authorUpton, Mathew
dc.contributor.authorLi, X
dc.contributor.authorMa, Z
dc.contributor.authorLiu, J
dc.contributor.authorLi, B
dc.date.accessioned2023-04-17T10:56:45Z
dc.date.issued2023-01-09
dc.identifier.issn2306-7381
dc.identifier.urihttps://pearl.plymouth.ac.uk/handle/10026.1/20712
dc.description.abstract

Streptococcus suis is a significant pathogen in pigs and a newly emerging zoonotic agent in humans. The presence of multiple serotypes and strains with diversified sequence types in pig herds highlights the need for the identification of broadly cross-reactive universal vaccine antigen targets, capable of providing cross-protection against S. suis infection. Subunit vaccines based on the conserved proteins shared between different S. suis serotypes are potential candidates for such a universally protective vaccine. In the present study, phosphate ABC transporter ATP-binding protein PstB (PstB), an immunogenic protein of the S. suis bacterium, was expressed and purified, and then subjected to cross-protection evaluation in mice. The PstB protein showed nearly 100% amino acid similarity across a panel of 31 S. suis isolates representing different serotypes, which were collected from different countries. A recombinant PstB (rPstB) protein (S. suis serotype 2) was recognized by rabbit sera specific to this serotype, and induced high levels of IFN-γ and IL-4 in mice immunized with the recombinant protein. These cytokines are considered important for protection against S. suis infection. Immunization of mice with rPstB resulted in an 87.5% protection against challenge with S. suis serotype 2 and 9 strains, suggesting a high level of cross-protection for S. suis serotypes 2 and 9. A lower protection rate (62.5%) was observed in mice challenged with the S. suis serotype 7 strain. These data demonstrate that PstB is a promising target antigen for development as a component of a universal subunit vaccine against multiple S. suis serotypes.

dc.format.extent48-48
dc.languageen
dc.publisherMDPI AG
dc.titleSubunit Vaccine Targeting Phosphate ABC Transporter ATP-Binding Protein, PstB, Provides Cross-Protection against Streptococcus suis Serotype 2, 7, and 9 in Mice
dc.typejournal-article
plymouth.issue1
plymouth.volume10
plymouth.journalVeterinary Sciences
dc.identifier.doi10.3390/vetsci10010048
plymouth.organisational-group|Plymouth
plymouth.organisational-group|Plymouth|Research Groups
plymouth.organisational-group|Plymouth|Faculty of Health
plymouth.organisational-group|Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group|Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED)|CBR
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA
plymouth.organisational-group|Plymouth|Users by role
plymouth.organisational-group|Plymouth|Users by role|Academics
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA|UoA01 Clinical Medicine
plymouth.organisational-group|Plymouth|Faculty of Health|School of Biomedical Sciences
plymouth.organisational-group|Plymouth|Users by role|Researchers in ResearchFish submission
plymouth.organisational-group|Plymouth|Research Groups|Plymouth Institute of Health and Care Research (PIHR)
dcterms.dateAccepted2023-01-05
dc.date.updated2023-04-17T10:56:40Z
dc.rights.embargodate2023-4-18
dc.identifier.eissn2306-7381
rioxxterms.versionofrecord10.3390/vetsci10010048


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV